Patent(s) and the Corresponding Patented Drug(s) |
Top |
World Intellectual Property Organization (WIPO) |
Patent ID |
WO2013096226 |
Title |
Trpv1 Antagonists. |
Abstract |
Disclosed herein are compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein X1, L, Rx, Ry, G, Z, A, m, n, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed. The compounds of formula (I) are useful as TRPV1 antagonists. |
Applicant(s) |
Abbvie Inc |
Representative Drug(s) |
D0A0YI |
Drug Info
|
IC50 = 20 nM |
Click to Show More |
[1] |
2
|
D0W4AA
|
Drug Info
|
IC50 = 48 nM
|
[1] |
3
|
D0NB5M
|
Drug Info
|
IC50 = 50 nM
|
[1] |
4
|
D0V3PI
|
Drug Info
|
IC50 = 56 nM
|
[1] |
Patent ID |
WO2013096223 |
Title |
Trpv1 Antagonists. |
Abstract |
Disclosed herein are compounds of formula (I), or pharmaceutically acceptable salts thereof, wherein X1, L, Rx, Ry, Rz, A, m, n, p, q, s, and positions a and b are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed. |
Applicant(s) |
Abbvie Inc |
Representative Drug(s) |
D0JC8L |
Drug Info
|
IC50 = 7 nM |
Click to Show More |
[1] |
2
|
D0R9RP
|
Drug Info
|
IC50 = 13 nM
|
[1] |
3
|
D0EV3G
|
Drug Info
|
IC50 = 16 nM
|
[1] |
4
|
D0A3XC
|
Drug Info
|
IC50 = 26 nM
|
[1] |
5
|
D0F4DI
|
Drug Info
|
IC50 = 36 nM
|
[1] |
6
|
D0IR7H
|
Drug Info
|
IC50 = 40 nM
|
[1] |
7
|
D05SWL
|
Drug Info
|
IC50 = 47 nM
|
[1] |
8
|
D0M4WY
|
Drug Info
|
IC50 = 60 nM
|
[1] |
Patent ID |
WO2013068467 |
Title |
Substituted Pyrazolyl-Based Carboxamide and Urea Derivatives Bearing A Phenyl Moiety Substituted with A Co-Containing Group As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a CO-containing group as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0MU3S |
Drug Info
|
IC50 = 0.3 nM |
Click to Show More |
[1] |
2
|
D0IN5E
|
Drug Info
|
IC50 = 0.5 nM
|
[1] |
Patent ID |
WO2013068462 |
Title |
Substituted Pyrazolyl-Based Carboxamide and Urea Derivatives Bearing A Phenyl Moiety Substituted with An N-Containing Group As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives of formula (R) bearing a phenyl moiety substituted with an N-containing group as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0P9KJ |
Drug Info
|
IC50 = 0.3 nM |
Click to Show More |
[1] |
2
|
D0DE5K
|
Drug Info
|
IC50 = 0.7 nM
|
[1] |
3
|
D0IU1H
|
Drug Info
|
IC50 = 0.9 nM
|
[1] |
Patent ID |
WO2013068461 |
Title |
Substituted Pyrazolyl-Based Carboxamide and Urea Derivatives Bearing A Phenyl Moiety Substituted with An O-Containing Group As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives of formula (Q) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D04FRL |
Drug Info
|
IC50 = 0.2 nM |
Click to Show More |
[1] |
2
|
D0U8YZ
|
Drug Info
|
IC50 = 0.6 nM
|
[1] |
3
|
D0K4SZ
|
Drug Info
|
IC50 = 0.7 nM
|
[1] |
Patent ID |
WO2013045451 |
Title |
Amine Substituted Methanesulfonamide Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to amine substituted methanesulfonamide derivatives of formula (I) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0JX4I |
Drug Info
|
IC50 = 1 nM |
Click to Show More |
[1] |
2
|
D0O9GI
|
Drug Info
|
IC50 = 1 nM
|
[1] |
Patent ID |
WO2013045447 |
Title |
Aryl or N-Heteroaryl Substituted Methanesulfonamide Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives of Formula (I) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D01PLJ |
Drug Info
|
IC50 = 1 nM |
Click to Show More |
[1] |
2
|
D0J9CS
|
Drug Info
|
IC50 = 3 nM
|
[1] |
Patent ID |
WO2013021276 |
Title |
Trpv1 Antagonists Including Dihydroxy Substituent and Uses Thereof. |
Abstract |
The disclosure relates to Compounds of Formula (I) and pharmaceutically acceptable derivatives thereof wherein Ar1, Ar2, L1 L2, X, R3, R22, and m are as defined herein, compositions comprising an effective amount of a Compound of Formula (I), and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a Compound of Formula (I). |
Applicant(s) |
Purdue Pharma Lp |
Representative Drug(s) |
D0IK1S |
Drug Info
|
IC50 = 29 nM |
Click to Show More |
[1] |
2
|
D01LGQ
|
Drug Info
|
IC50 = 30 nM
|
[1] |
3
|
D0F3HP
|
Drug Info
|
IC50 = 32 nM
|
[1] |
Patent ID |
WO2013013817 |
Title |
Substituted Heterocyclic Aza Derivatives. |
Abstract |
The invention relates to heterocyclic aza derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D07EGF |
Drug Info
|
IC50 = 1 nM |
Click to Show More |
[1] |
2
|
D0F5NQ
|
Drug Info
|
IC50 = 1 nM
|
[1] |
Patent ID |
WO2013013816 |
Title |
Substituted Bicyclic Aromatic Carboxamide and Urea Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D03QAW |
Drug Info
|
IC50 = 0.1 nM |
Click to Show More |
[1] |
2
|
D00QEZ
|
Drug Info
|
IC50 = 0.4 nM
|
[1] |
Patent ID |
WO2013013815 |
Title |
Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D07FIY |
Drug Info
|
IC50 = 0.6 nM |
Click to Show More |
[1] |
2
|
D0P5SB
|
Drug Info
|
IC50 = 1 nM
|
[1] |
Patent ID |
WO2012176061 |
Title |
Trpv1 Antagonists Including Dihydroxy Substituent and Uses Thereof. |
Abstract |
The disclosure relates to Compounds of Formula (I) and pharmaceutically acceptable derivatives thereof, where R1, R4, R8, R9, and m are as defined herein, compositions comprising an effective amount of a Compound of Formula (I) or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, pain associated with osteoarthritis, osteoarthritis, UI, an ulcer, IBD, and IBS, comprising administering to an animal in need thereof an effective amount of a Compound of Formula (I) or a pharmaceutically acceptable derivative thereof. |
Applicant(s) |
Purdue Pharma Lp |
Representative Drug(s) |
D05RBF |
Drug Info
|
IC50 = 40 nM |
Click to Show More |
[1] |
2
|
D0Y1SI
|
Drug Info
|
IC50 = 62 nM
|
[1] |
3
|
D0KF3A
|
Drug Info
|
IC50 = 96 nM
|
[1] |
Patent ID |
WO2012134943 |
Title |
Trpv1 Antagonists. |
Abstract |
Disclosed herein are compounds of formula (I) or pharmaceutically acceptable salts, solvates, or combinations thereof, (I) wherein X1, X2, X3, X4, J, K, L, X5, X6, Rb, G2, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed. |
Applicant(s) |
Abbvie Inc |
Representative Drug(s) |
D06VYF |
Drug Info
|
IC50 = 2 nM |
Click to Show More |
[1] |
2
|
D08ICT
|
Drug Info
|
IC50 = 2.3 nM
|
[1] |
3
|
D0HE7X
|
Drug Info
|
IC50 = 3.3 nM
|
[1] |
4
|
D0KB2Z
|
Drug Info
|
IC50 = 4 nM
|
[1] |
5
|
D0C1MZ
|
Drug Info
|
IC50 = 5 nM
|
[1] |
6
|
D0C8ZZ
|
Drug Info
|
IC50 = 5.4 nM
|
[1] |
7
|
D00YXA
|
Drug Info
|
IC50 = 5.6 nM
|
[1] |
8
|
D0R8GA
|
Drug Info
|
IC50 = 8.2 nM
|
[1] |
9
|
D0ON4M
|
Drug Info
|
IC50 = 10 nM
|
[1] |
10
|
D02OAH
|
Drug Info
|
IC50 = 11 nM
|
[1] |
11
|
D0O7IQ
|
Drug Info
|
IC50 = 12 nM
|
[1] |
12
|
D0IP5E
|
Drug Info
|
IC50 = 29 nM
|
[1] |
13
|
D0N9FJ
|
Drug Info
|
IC50 = 30 nM
|
[1] |
14
|
D0GZ4G
|
Drug Info
|
IC50 = 64 nM
|
[1] |
Patent ID |
WO2012072512 |
Title |
N-Cyclobutyl-Imidazopyridine or -Pyrazolopyridine Carboxamides As Trpv1 Antagonists. |
Abstract |
A compound of formula (I) wherein X1 represents a hydrogen atom, or a CH2OH group X2 represents a hydrogen atom, a fluorine atom, an OCH3 group or a CH2OH group, and at least one of X1 and X2 is hydrogen Y represents a carbon atom and Z represents a nitrogen atom or Y represents a nitrogen atom and Z represents a carbon atom; R1 represents a halogen atom, a C1-4 alkyl group, a trifluoromethyl group or a trifluoromethoxy group, and R2 are R3 each independently selected from a hydrogen atom, a halogen atom, a C1-4 alkyl group, a trifluoromethyl group or a trifluoromethoxy group; or a pharmaceutically acceptable salt or solvate thereof. |
Applicant(s) |
Glaxo Group Limited |
Representative Drug(s) |
D0IT4N |
Drug Info
|
IC50 = 0.79 nM |
Click to Show More |
[1] |
2
|
D04HCS
|
Drug Info
|
IC50 = 1.26 nM
|
[1] |
3
|
D03ZOZ
|
Drug Info
|
IC50 = 2 nM
|
[1] |
4
|
D0O6VU
|
Drug Info
|
IC50 = 3.98 nM
|
[1] |
5
|
D00ODY
|
Drug Info
|
IC50 = 6.31 nM
|
[1] |
6
|
D0ZQ2W
|
Drug Info
|
IC50 = 10 nM
|
[1] |
Patent ID |
WO2012050380 |
Title |
Novel Pyridyl Benzoxazine Derivatives, Pharmaceutical Composition Comprising The Same, and Use Thereof. |
Abstract |
Discloses is a benzoxazine benzimidazole derivative, represented by Chemical Formula 1, functioning as an antagonist to the vanilloid receptor-1, a pharmaceutical composition comprising the same, and the use thereof. The benzoxazine benzimidazole derivative can be useful for preventing or treating a disease associated with antagonistic activity of vanilloid receptor-1, without hyperthermia. |
Applicant(s) |
Daewoong Pharmaceutical Co., Ltd |
Representative Drug(s) |
D03VXP |
Drug Info
|
IC50 = 20 to 100 nM |
Click to Show More |
[1] |
2
|
D0G6IQ
|
Drug Info
|
IC50 < 20 nM
|
[1] |
3
|
D0Z5HH
|
Drug Info
|
IC50 = 20 to 100 nM
|
[1] |
Patent ID |
WO2012045729 |
Title |
Imidazo [1, 2 -A] Pyridine and Pyrazolo [1, 5 -A] Pyridine Derivatives As Trpv1 Antagonists. |
Abstract |
A compound of formula of formula (I) wherein A represents a single bond, a CH2 group or a CH (Me) group; X1 represents a hydrogen atom, a fluorine atom or a methyl group; X2 represents a hydrogen atom, a fluorine atom, a methyl group or a CH2OH group; X3 represents a hydrogen atom, a fluorine atom or a CH2OH group, and at least two of X1, X2 and X3 are hydrogen; Y represents a C atom and Z represents a N atom or Y represents an N atom and Z represents a C atom. R1 represents a halogen atom, a C1-4 alkyl group, a trifluoromethyl group or a trifluoromethoxy group, and R2 and R3 are each independently selected from a hydrogen atom, a halogen atom, a C1-4 alkyl group, a trifluoromethyl group or a trifluoromethoxy group. or a pharmaceutically acceptable salt or solvate thereof. salt or solvate thereof. |
Applicant(s) |
Glaxo Group Limited |
Representative Drug(s) |
D0O0UG |
Drug Info
|
IC50 = 12.59 nM |
Click to Show More |
[1] |
2
|
D0C9FN
|
Drug Info
|
IC50 < 15.58 nM
|
[1] |
Patent ID |
WO2011162409 |
Title |
Compounds Having Trpv1 Antagonistic Activity and Uses Thereof. |
Abstract |
The invention relates to compounds of Formula I and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof. |
Applicant(s) |
Shionogi & Co., Ltd |
Representative Drug(s) |
D0D2CF |
Drug Info
|
IC50 = 1 nM |
Click to Show More |
[1] |
2
|
D0A8LU
|
Drug Info
|
IC50 = 10 nM
|
[1] |
3
|
D0PT0U
|
Drug Info
|
IC50 = 12 nM
|
[1] |
4
|
D05SMP
|
Drug Info
|
IC50 < 50 nM
|
[1] |
5
|
D07FWF
|
Drug Info
|
IC50 < 50 nM
|
[1] |
6
|
D08YAL
|
Drug Info
|
IC50 < 50 nM
|
[1] |
7
|
D0C5NT
|
Drug Info
|
IC50 < 50 nM
|
[1] |
8
|
D0E0SA
|
Drug Info
|
IC50 < 50 nM
|
[1] |
Patent ID |
WO2010127856 |
Title |
Substituted Phenylureas and Phenylamides As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted phenylureas and phenylamides of formula (I), to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions. |
Applicant(s) |
Robert Bahrenberg, et al |
Representative Drug(s) |
D07EAV |
Drug Info
|
IC50 = 0.1 nM |
Click to Show More |
[1] |
2
|
D09ZWU
|
Drug Info
|
IC50 = 0.1 nM
|
[1] |
Patent ID |
WO2010127855 |
Title |
Substituted Aromatic Carboxamide and Urea Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted aromatic carboxamide and urea derivatives, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions (formula (I)). |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0TZ2W |
Drug Info
|
IC50 = 0.07 nM |
Click to Show More |
[1] |
2
|
D06JHW
|
Drug Info
|
IC50 = 0.2 nM
|
[1] |
Patent ID |
WO2010045402 |
Title |
Trpv1 Antagonists. |
Abstract |
Disclosed herein are compounds of formula (I), or pharmaceutically acceptable salts, solvates, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed. |
Applicant(s) |
Abbott Laboratories |
Representative Drug(s) |
D02QJE |
Drug Info
|
IC50 = 4 nM |
Click to Show More |
[1] |
2
|
D0HS1D
|
Drug Info
|
IC50 = 5 nM
|
[1] |
3
|
D0YR4E
|
Drug Info
|
IC50 = 8 nM
|
[1] |
Patent ID |
WO2010045401 |
Title |
Trpv1 Antagonists. |
Abstract |
Disclosed herein are compounds of Formula (I), or pharmaceutically acceptable salts, solvates, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed. |
Applicant(s) |
Abbott Laboratories |
Representative Drug(s) |
D0F4YX |
Drug Info
|
IC50 = 4 nM |
Click to Show More |
[1] |
2
|
D0NM3D
|
Drug Info
|
IC50 = 4 nM
|
[1] |
3
|
D0ZM8H
|
Drug Info
|
IC50 = 4 nM
|
[1] |
4
|
D0JK2N
|
Drug Info
|
IC50 = 5 nM
|
[1] |
5
|
D07JNJ
|
Drug Info
|
IC50 = 9 nM
|
[1] |
6
|
D0SD4G
|
Drug Info
|
IC50 = 10 nM
|
[1] |
Patent ID |
WO2013068464 |
Title |
Substituted Pyrazolyl-Based Carboxamide and Urea Derivatives Bearing A Phenyl Moiety Substituted with An So2-Containing Group As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a S02-containing group as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0OA1P |
Drug Info
|
IC50 = 4 nM |
[1] |
Patent ID |
WO2013068463 |
Title |
Substituted Pyrazolyl-Based Carboxamide and Urea Derivatives Bearing A Phenyl Moiety Substituted with An N-Cyclic Group As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an N-cyclic group as vanilloid receptor ligands formula (S) to pharmaceutical compositions containing these compounds of the general formula (S) and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0U5CQ |
Drug Info
|
IC50 = 15 nM |
[1] |
Patent ID |
WO2013045452 |
Title |
Substituted Methanesulfonamide Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted methanesulfonamide derivatives as vanilloid receptor ligands of formula (I), to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0Y9ST |
Drug Info
|
IC50 = 1 nM |
[1] |
Patent ID |
WO2012062463 |
Title |
Substituted Bicyclic Carboxamide and Urea Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted bicyclic carboxamide and urea derivatives, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0B0WJ |
Drug Info
|
IC50 = 7.7 nM |
[1] |
Patent ID |
WO2012062462 |
Title |
Substituted Heteroaromatic Carboxamide and Urea Derivatives As Vanilloid Receptor Ligands. |
Abstract |
The invention relates to substituted heteroaromatic carboxamide and urea derivatives of formula (I), to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions. |
Applicant(s) |
Gruenenthal Gmbh |
Representative Drug(s) |
D0X1OO |
Drug Info
|
IC50 = 0.4 nM |
[1] |
Patent ID |
WO2012022487 |
Title |
Substituted Cyclic Carboxamide and Urea Derivatives As Ligands of The Vanilloid Receptor. |
Abstract |
The invention relates to substituted cyclic carboxamide and urea derivatives, to processes for their preparation, to pharmaceuticals containing these compounds, and to the use of these compounds for the preparation of pharmaceuticals. |
Applicant(s) |
Frank, Robert et al |
Representative Drug(s) |
D0G3UV |
Drug Info
|
IC50 = 10 nM |
[1] |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US20148889690 |
Title |
Trpv1 Antagonists Including Dihydroxy Substituent and Uses Thereof. |
Applicant(s) |
Purdue Pharma Lp |
Representative Drug(s) |
D01RUK |
Drug Info
|
IC50 = 38.7 nM |
Click to Show More |
[1] |
2
|
D0ZP2C
|
Drug Info
|
IC50 = 85.3 nM
|
[1] |
Patent ID |
US20148673895 |
Title |
Tetrahydropyrimidoazepines As Modulators of Trpv1. |
Applicant(s) |
Janssen Pharmaceutica Nv |
Representative Drug(s) |
D01HED |
Drug Info
|
IC50 = 18 nM |
Click to Show More |
[1] |
2
|
D0N0TF
|
Drug Info
|
IC50 = 25 nM
|
[1] |
3
|
D0NV2M
|
Drug Info
|
IC50 = 32 nM
|
[1] |
4
|
D0K3KE
|
Drug Info
|
IC50 = 49 nM
|
[1] |
Patent ID |
US20148637527 |
Title |
Imidazolo-, Oxazolo-, and Thiazolopyrimidine Modulators of Trpv1. |
Applicant(s) |
Janssen Pharmaceutica Nv |
Representative Drug(s) |
D0XX8R |
Drug Info
|
IC50 = 4 nM |
Click to Show More |
[1] |
2
|
D0LA0Q
|
Drug Info
|
IC50 = 6 nM
|
[1] |
3
|
D0I3ZW
|
Drug Info
|
IC50 = 8 nM
|
[1] |
4
|
D0Z4QQ
|
Drug Info
|
IC50 = 15 nM
|
[1] |
Patent ID |
US20130243711 |
Title |
Novel Trpv1 Inhibitory Peptides and Composition for Skin-Aging Protection or Wrinkle Improvement Comprising The Same. |
Applicant(s) |
Snu R & Db Foundation |
Representative Drug(s) |
D03SHM |
Drug Info
|
IC50 = 1.3 to 100 nM |
Click to Show More |
[1] |
2
|
D05ZWR
|
Drug Info
|
IC50 = 1.3 to 100 nM
|
[1] |
3
|
D0V9RM
|
Drug Info
|
IC50 = 1.3 to 100 nM
|
[1] |
4
|
D0WJ8R
|
Drug Info
|
IC50 = 1.3 to 100 nM
|
[1] |
Patent ID |
US20128173841 |
Title |
Tetrahydro-Naphthalene Derivatives. |
Applicant(s) |
Xention Ltd |
Representative Drug(s) |
D00OLY |
Drug Info
|
IC50 <= 100 nM |
Click to Show More |
[1] |
2
|
D0JT8B
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
3
|
D0K3KM
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
4
|
D0N0QN
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
Patent ID |
US20120184571 |
Title |
Quinazolinone Derivatives Useful As Vanilloid Antagonists. |
Applicant(s) |
Novartis Ag |
Representative Drug(s) |
D02JQB |
Drug Info
|
IC50 = 4 to 30000 nM |
Click to Show More |
[1] |
2
|
D07XZR
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
3
|
D08UEC
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
4
|
D0CR0H
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
5
|
D0K0ZI
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
6
|
D0KM0W
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
7
|
D0NH2M
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
8
|
D0O3TG
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
9
|
D0RC7L
|
Drug Info
|
IC50 = 4 to 30000 nM
|
[1] |
Patent ID |
US20120115827 |
Title |
3-Aminobenzamide Compounds and Vanilloid Receptor Subtype 1 (Vr1) Inhibitors. |
Applicant(s) |
Japan Tobacco, Inc |
Representative Drug(s) |
D03FSF |
Drug Info
|
IC50 <= 100 nM |
Click to Show More |
[1] |
2
|
D07BZW
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
3
|
D08ZBB
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
4
|
D09QXC
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
5
|
D0B4NI
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
6
|
D0CX4C
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
7
|
D0DC4O
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
8
|
D0DE5I
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
9
|
D0EC3Z
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
10
|
D0H4TR
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
11
|
D0H6CX
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
12
|
D0OC6A
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
13
|
D0QP4N
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
14
|
D0UE9K
|
Drug Info
|
IC50 <= 100 nM
|
[1] |
Patent ID |
US20110212952 |
Title |
3,4-Dihydrobenzoxazine Compounds and Inhibitors of Vanilloid Receptor Subtype 1 (Vr1) Activity. |
Applicant(s) |
Japan Tobacco, Inc |
Representative Drug(s) |
D03EEA |
Drug Info
|
IC50 = 0.019 nM |
Click to Show More |
[1] |
2
|
D0GV5G
|
Drug Info
|
IC50 = 0.024 nM
|
[1] |
3
|
D0YM1M
|
Drug Info
|
IC50 = 0.038 nM
|
[1] |
4
|
D0ZZ8F
|
Drug Info
|
IC50 = 0.038 nM
|
[1] |
5
|
D03YFL
|
Drug Info
|
IC50 = 0.15 nM
|
[1] |
6
|
D0E8UP
|
Drug Info
|
IC50 = 0.69 nM
|
[1] |
Patent ID |
US20110152318 |
Title |
Novel Compounds, Isomer Thereof, or Pharmaceutically Acceptable Salts Thereof As Vanilloid Receptor Antagonist and Pharmaceutical Compositions Containing The Same. |
Applicant(s) |
Amorepacific Corp |
Representative Drug(s) |
D01DNH |
Drug Info
|
IC50 = 30 nM |
Click to Show More |
[1] |
2
|
D04TIU
|
Drug Info
|
IC50 = 42 nM
|
[1] |
3
|
D0AQ3U
|
Drug Info
|
IC50 = 45 nM
|
[1] |
4
|
D0YU9B
|
Drug Info
|
IC50 = 48 nM
|
[1] |
5
|
D0ZS3E
|
Drug Info
|
IC50 = 64 nM
|
[1] |
Patent ID |
US20120184509 |
Title |
Compounds As Trvp1 Blockers, Pharmaceutical Compositions and Medical Uses Thereof. |
Representative Drug(s) |
D0R2VB |
Drug Info
|
IC50 = 0.5 nM |
Click to Show More |
[1] |
2
|
D0D4NX
|
Drug Info
|
IC50 = 2.3 nM
|
[1] |
3
|
D0ZE1M
|
Drug Info
|
IC50 = 5.4 nM
|
[1] |
Patent ID |
US20148716272 |
Title |
N-(Amino-Heteroaryl)-1Hpyrrolopyridine-2-Carboxamides Derivatives Preparation Thereof and Their Use In Therapy. |
Applicant(s) |
Sanofi |
Representative Drug(s) |
D01GEK |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D07RYM
|
Drug Info
|
N.A.
|
[1] |
3
|
D0WT1W
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20128288376 |
Title |
Tricyclic N-Heteroarylcarboxamide Derivatives Containing A Benzimidazole Unit, Method for Preparing Same and Their Therapeutic Use. |
Applicant(s) |
Sanofi-Aventis |
Representative Drug(s) |
D07MNI |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09SMA
|
Drug Info
|
N.A.
|
[1] |
3
|
D0DI1R
|
Drug Info
|
N.A.
|
[1] |
4
|
D0PJ8O
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20148765733 |
Title |
Amine Substituted Methanesulfonamide Derivatives As Vanilloid Receptor Ligands. |
Applicant(s) |
Grunenthal Gmbh |
Representative Drug(s) |
D0P0MR |
Drug Info
|
IC50 = 4 nM |
[1] |
Patent ID |
US20148637548 |
Title |
Therapeutic Agents Useful for Treating Pain. |
Applicant(s) |
Purdue Pharma Lp |
Representative Drug(s) |
D0MY3K |
Drug Info
|
IC50 = 19 nM |
[1] |
Patent ID |
US20130345255 |
Title |
Trpv1 Antagonists. |
Applicant(s) |
Abbvie, Inc |
Representative Drug(s) |
D0N2UQ |
Drug Info
|
IC50 = 54 nM |
[1] |